April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
GemCis-NabPaclitaxel vs. GemCis in first line of advanced biliary tract cancers
Dec 16, 2024, 17:31

GemCis-NabPaclitaxel vs. GemCis in first line of advanced biliary tract cancers

Erman Akkus shared on X:

GemCis-NabPaclitaxel vs. GemCis in 1L of advanced biliary tract cancers

SWOG S1815

No PFS or OS benefit

PFS benefit in gallbladder cancer subgroup.

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers 

Authors: Rachna T. Shroff, Gentry King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura Goff,  Khalid Matin, Amit Mahipal, Aparna Kalyan, Milind M. Javle, Imane El Dika, Benjamin Tan, Puneet Cheema, Anuj Patel, Renuka Iyer, R. Katie Kelley, Jaykumar Thumar,  Anthony El-Khoueiry, Katherine A. Guthrie, E. Gabriela Chiorean, Howard Hochster, and Philip A. Philip.

GemCis-NabPaclitaxel vs. GemCis in first line of advanced biliary tract cancers